InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
2
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-9.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Walker Marlan D, Conseiller Juridique. Officer active across 1 company, notably TherapeuticsMD, Inc.. Aggregated, 9 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €1k. History available since 6 December 2022. The latest transaction was disclosed on 14 April 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Walker Marlan D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报9 总计
490 股@ US$0.998532.2% 占其流量Common StockSEC:0000905148-25-001215:0
标准退出：2025年7月13日 (T+90)
1,136 股@ US$0.874767.8% 占其流量Common StockSEC:0000905148-25-001190:0
标准退出：2025年7月8日 (T+90)
3,467 股0Common StockSEC:0000905148-25-000737:0
70,000 股0Common StockSEC:0001209191-23-057725:0
1,010 股0Common StockSEC:0001209191-23-027361:0
3,030 股0Common StockSEC:0001209191-23-024388:0
1,010 股0Common StockSEC:0001209191-22-060587:0
230,000 股Common StockSEC:0001209191-22-018682:0
50,500 股Common StockSEC:0001387131-21-005570:0
9 条申报中的 9 条
About Walker Marlan D
Marlan D. Walker is the General Counsel of TherapeuticsMD, Inc. He is responsible for the company's legal affairs, including regulatory compliance and legal risk management. His expertise in business law is essential to support TherapeuticsMD's operations.
